LCD ID Number: L37863 Status: A-Approved
LCD Title: Voretigene Neparvovec-rzyl (Luxturna®)
Geographic Jurisdiction: Georgia Other Jurisdictions
Original Determination Effective Date:
05/06/2019
Original Determination Ending Date:
Revision Effective Date:
04/20/2023
Revision End Date:
CMS National Coverage Policy:
Title XVIII of the Social Security Act, §1862(a)(1)(A) allows coverage and payment for only those services that are considered to be reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of a malformed body member.
Title XVIII of the Social Security Act, §1862(a)(1)(D) refers to limitations on items or devices that are investigational or experimental.
CMS Internet-Only Manual, Pub. 100-02, Medicare Benefit Policy Manual, Chapter 15, §50 Drugs and Biologicals
Sorry, you need to login or register to view additional sections of this Medicare policy.
*
|